Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05620134 |
| Title | A Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, in Patients With Unresectable Locally Advanced or Metastatic Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Salubris Biotherapeutics Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Jules Bordet | Brussels | 1070 | Belgium | Details | ||
| UZA | Edegem | Belgium | Details | |||
| UZ Ghent | Ghent | 9000 | Belgium | Details | ||
| CHU UCL Namur - site Godinne | Yvoir | Belgium | Details | |||
| NEXT Oncology Barcelona | Barcelona | Spain | Details | |||
| Vall d Hebron Institute of Oncology VHIO | Barcelona | Spain | Details | |||
| Next Oncology Madrid Hospital Quironsalud Madrid | Madrid | Spain | Details | |||
| NEXT Oncology Madrid | Madrid | Spain | Details | |||
| START Madrid | Madrid | Spain | Details | |||
| University Hospital October 12 | Madrid | Spain | Details | |||
| Instituto de Investigación Sanitaria INCLIVA | Valencia | Spain | Details |